Jonathan D Schwartz Selected Research

Jonathan D Schwartz Research Topics

Disease

11	Neoplasms (Cancer) 01/2022 - 06/2004
8	Hepatocellular Carcinoma (Hepatoma) 07/2015 - 10/2002
7	Disease Progression 05/2020 - 06/2008
4	Hypertension (High Blood Pressure) 07/2015 - 01/2014
3	Adenocarcinoma 10/2014 - 01/2004
2	Fanconi Anemia (Fanconi's Anemia) 05/2020 - 01/2019
2	Congenital Abnormalities (Deformity) 05/2020 - 01/2019
2	Liver Diseases (Liver Disease) 07/2015 - 06/2004
2	Liver Neoplasms (Liver Cancer) 07/2015 - 12/2013
2	Fatigue 10/2014 - 09/2014
2	Stomach Neoplasms (Stomach Cancer) 10/2014 - 01/2014
2	Diarrhea 09/2014 - 12/2010
2	Melanoma (Melanoma, Malignant) 08/2014 - 12/2010
2	Renal Cell Carcinoma (Grawitz Tumor) 06/2014 - 04/2002
2	Neoplasm Metastasis (Metastasis) 02/2010 - 02/2010
1	Brain Neoplasms (Brain Tumor) 01/2022
1	Pyruvate Kinase Deficiency of Red Cells 01/2022
1	Osteopetrosis 03/2021
1	Glioma (Gliomas) 01/2021
1	Hematologic Neoplasms (Hematological Malignancy) 05/2020
1	Bone Marrow Failure Disorders 05/2020
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2019
1	Prostatic Neoplasms (Prostate Cancer) 09/2015
1	Ascites 07/2015
1	Thrombocytopenia (Thrombopenia) 07/2015
1	Asthenia 07/2015
1	Abdominal Pain (Pain, Abdominal) 10/2014
1	Neutropenia 10/2014
1	Ovarian Neoplasms (Ovarian Cancer) 09/2014
1	Headache (Headaches) 09/2014
1	Carcinoma (Carcinomatosis) 09/2014
1	Nausea 09/2014
1	Colorectal Neoplasms (Colorectal Cancer) 04/2014
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2004

Drug/Important Bio-Agent (IBA)

9	RamucirumabIBA 09/2015 - 12/2013
6	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 07/2015 - 06/2008
5	Monoclonal AntibodiesIBA 10/2014 - 06/2008
3	Pharmaceutical PreparationsIBA 01/2022 - 01/2014
3	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 10/2014 - 01/2014
3	Biological ProductsIBA 01/2014 - 06/2008
2	A-Form DNA (A-DNA)IBA 05/2020 - 01/2019
2	cixutumumabIBA 09/2015 - 12/2011
2	PlatinumIBA 10/2014 - 01/2014
2	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 09/2014 - 04/2014
1	mitapivatIBA 01/2022
1	MutagensIBA 05/2020
1	tisagenlecleucelIBA 01/2019
1	Mitoxantrone (Novantrone)FDA LinkGeneric 09/2015
1	Prednisone (Sone)FDA LinkGeneric 09/2015
1	Docetaxel (Taxotere)FDA Link 09/2015
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 07/2015
1	Sorafenib (BAY 43-9006)FDA Link 07/2015
1	BilirubinIBA 07/2015
1	Paclitaxel (Taxol)FDA LinkGeneric 10/2014
1	AnthracyclinesIBA 10/2014
1	Dacarbazine (DIC)FDA LinkGeneric 08/2014
1	Tyrosine Kinase InhibitorsIBA 06/2014
1	Biomarkers (Surrogate Marker)IBA 12/2013
1	Insulin-Like PeptidesIBA 12/2011
1	Hormones (Hormone)IBA 12/2011
1	IpilimumabIBA 12/2010
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 02/2010
1	Phosphotransferases (Kinase)IBA 02/2010
1	Cytotoxins (Cytolysins)IBA 02/2010
1	Immunoglobulin G (IgG)IBA 02/2010
1	Platelet-Derived Growth Factor alpha ReceptorIBA 02/2010
1	Vascular Endothelial Growth Factor Receptor-1 (fms-Like Tyrosine Kinase)IBA 02/2010
1	IMC-18F1IBA 02/2010
1	olaratumabIBA 02/2010
1	Neutralizing AntibodiesIBA 02/2010
1	Platelet-Derived Growth FactorIBA 02/2010
1	CytokinesIBA 02/2010
1	Transforming Growth Factor beta (TGF-beta)IBA 02/2010
1	Transforming Growth Factor beta Receptors (TGF beta Receptors)IBA 02/2010
1	Bevacizumab (Avastin)FDA Link 06/2008
1	Thalidomide (Thalomid)FDA Link 10/2005
1	Gemcitabine FDA Link 01/2004
1	Trastuzumab (Herceptin)FDA Link 01/2004

Therapy/Procedure

12	Therapeutics 01/2022 - 10/2002
4	Drug Therapy (Chemotherapy) 10/2014 - 02/2010
1	Precision Medicine 01/2021
1	Castration 09/2015
1	Liver Transplantation 04/2004
1	Nephrectomy 04/2002